aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Acclinate: A digital health firm enhancing inclusive clinical research via culturally-aware tech solutions.
Acclinate is a digital health company focused on enhancing inclusive clinical research through culturally-aware technology solutions. They assist pharmaceutical companies, CROs, and healthcare organizations in accessing and engaging communities of color, ensuring research efforts are more representative of diverse populations.
Acclinate has made significant strides in promoting diversity in clinical research, positively impacting the inclusivity of medical studies. Their innovative approach has garnered attention and support from key stakeholders in the healthcare industry, contributing to more equitable health outcomes.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Healthcare, Clinical Research
Technology
AI, Machine Learning
Tags
Healthtech, Data
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
Global
When was Acclinate founded?
Acclinate was founded in 2020.
Where is Acclinate’s headquarters located?
Acclinate’s headquarters is located in Huntsville, AL, US.
When was Acclinate’s last funding round?
Acclinate’s most recent funding round was for $4.9M (USD) in October 2022.
How many employees does Acclinate have?
Acclinate has 24 employees as of Feb 5, 2024.
How much has Acclinate raised to-date?
As of July 05, 2023, Acclinate has raised a total of $6.5M (USD) since Oct 19, 2022.
Add Comparison
Total Raised to Date
$6.5M
USD
Last Update Oct 19, 2022
Last Deal Details
$4.9M
USD
Oct 19, 2022
Series Unknown
Total Employees Over Time
24
As of Feb 2024
Acclinate Address
601 Genome Way
Suite 3400
Huntsville,
Alabama
35806
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts